Mooncity
liked
Mooncity
liked

19
Mooncity
liked
Expansion plans, IP growth, Partnerships… why not?
MINSO bought in at 21.70, still expecting a pullback to support level, will continue to buy in more if it hits below 21!
MINSO bought in at 21.70, still expecting a pullback to support level, will continue to buy in more if it hits below 21!
loading...
5
Mooncity
liked
Mooncity
liked
$Harrow (HROW.US)$
Guys I'm not usually one to brag, because like everyone else I win some and lose some, but check out this chart... tell me my timing wasn't just perfect lol
Guys I'm not usually one to brag, because like everyone else I win some and lose some, but check out this chart... tell me my timing wasn't just perfect lol

16
1
Mooncity
liked
$XIAOMI-W (01810.HK)$ Revenue
Estimate: Analysts forecast Q4 2024 revenue around 102.21 billion CNY (approximately $14.1 billion USD), per S&P estimates cited by Moomoo. This aligns with Xiaomi’s strong growth trajectory, following Q3 2024’s 92.5 billion CNY (30.5% YoY increase) and Q4 2023’s 73.24 billion CNY (10.9% YoY increase).
Drivers:
Smartphones: Q4 typically benefits from holiday sales. Analysts expect 40–45 million units shipped, maintaining Xiaomi’s 14% global market sh...
Estimate: Analysts forecast Q4 2024 revenue around 102.21 billion CNY (approximately $14.1 billion USD), per S&P estimates cited by Moomoo. This aligns with Xiaomi’s strong growth trajectory, following Q3 2024’s 92.5 billion CNY (30.5% YoY increase) and Q4 2023’s 73.24 billion CNY (10.9% YoY increase).
Drivers:
Smartphones: Q4 typically benefits from holiday sales. Analysts expect 40–45 million units shipped, maintaining Xiaomi’s 14% global market sh...
5
2
Mooncity
liked
$Guardant Health (GH.US)$ $Tempus AI (TEM.US)$ $Hims & Hers Health (HIMS.US)$
To compare the stocks of Hims & Hers Health (HIMS), Guardant Health (GH), and Tempest Therapeutics (TEM) and determine which might be the most valuable to buy at their closing prices on March 11, 2025 (HIMS at $34.71, GH at $42.36, and TEM at $45.58), we’ll evaluate them based on key factors such as their business models, recent performance, valuation metrics, growth potential, and market sentiment. Since I don’t have real-...
To compare the stocks of Hims & Hers Health (HIMS), Guardant Health (GH), and Tempest Therapeutics (TEM) and determine which might be the most valuable to buy at their closing prices on March 11, 2025 (HIMS at $34.71, GH at $42.36, and TEM at $45.58), we’ll evaluate them based on key factors such as their business models, recent performance, valuation metrics, growth potential, and market sentiment. Since I don’t have real-...
9
1
2